|
|
"It
has became apparent that in order to substantially impact
the number of patients enrolled in clinical trials, the community
oncologist needed to be included as a partner in the process.
It is well documented that cancer patients want to receive
the best possible care close to home, in their community,
near friends and family"
|
|
-Craig
Henderson, MD
Professor of Medicine, UCSF
President/CEO, Access Oncology
|
More
than 80 percent of all cancer care is now provided at the community
level, as is 60 percent of all clinical cancer research. This significant
demand for community-based cancer-care services continues to grow
and to meet these evolving needs; new models for the delivery of
cancer care are also emerging. With over 400 cancer drugs in the
research pipeline in the US, and the fact that only 3% to 5% of
cancer patients are enrolled in clinical trials, there is an urgent
need to expand clinical trials outside the traditional academic
setting.
Suburban
Hematology-Oncology Associates is partnering with many
research networks, both in Georgia and across the United States,
to continuously enhance the delivery of state-of-the-art cancer
care.
Our
physicians are affiliated with the following entities:
Atlanta Regional Community
Clinical Oncology Program (ARCCOP): The Community Clinical Oncology
Program (CCOP) was initiated by the National
Cancer Institute (NCI) in 1983 to provide community hospitals
access to a wide range of clinical research studies. Prior to this,
a patient had to travel to one of a few select research institutions
in the country or to the NCI itself to receive the newest treatments.
This meant leaving familiar surroundings of home, family and workplace.
As well, oncology physician specialists in your community wanted
to be part of the search for answers to cure cancer and to offer
you the best treatments available. The ARCCOP, on average, has approximately
40-50 clinical trials open.
Georgia
Oncology Partners Research and Education Foundation (GOP):
The GOP Foundation is organized as a 501(c)(3)company and is governed
by a board of directors and consisting of clinical investigators
and non-investigator representatives. GOP contracts with medical
practices in Georgia to provide investigators clinical trials. The
GOP mission is to conduct high quality investigational new drug
treatment clinical trials for cancer patients in a community practice
setting.
UCLA/Translational
Oncology Research Institute (TORI): TORI is a UCLA based
Network that consists of investigators located at various research
sites throughout the US and internationally that collaborate to
conduct large-scale studies addressing therapeutics and cancer pharmaceuticals.
The GOP has contracted with TORI to be a part of and participate
in the TORI network.
National Oncology Alliance Online Collaborative Oncology Group (NOA-OCOG):
The NOA-OCOG Research Alliance brings together a large number of
community-based oncologists capable of participating in clinical
trials and matches them to clinical trials sponsored by biotechnology
and pharmaceutical companies. OCOG is a research organization that
facilitates the ability of private-practice, community-based oncologists
to participate in clinical research studies, with access to novel
cancer drugs through the latest and most pivotal clinical research
studies.
|
